Title : Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes.

Pub. Date : 1988 Sep

PMID : 3044889






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To evaluate possible mechanisms by which insulin inhibits hepatic apolipoprotein B (apoB) secretion, we incubated primary cultures of rat hepatocytes with sodium orthovanadate, a phosphotyrosine phosphatase inhibitor and insulin-mimetic agent. Sodium orthovanadate apolipoprotein B Rattus norvegicus
2 Vanadate (10 microM) and insulin (10 nM) inhibited the medium accumulation of apoB (secretion) by 21 and 37%, respectively, without increasing intracellular apoB. Vanadates apolipoprotein B Rattus norvegicus
3 Unlike insulin, vanadate, at a concentration that inhibited apoB secretion (10 microM), had no effect on intracellular lipogenesis, inhibited the secretion of newly synthesized hepatic proteins, and had a delayed onset and termination of action on inhibition of apoB secretion. Vanadates apolipoprotein B Rattus norvegicus
4 Unlike insulin, vanadate, at a concentration that inhibited apoB secretion (10 microM), had no effect on intracellular lipogenesis, inhibited the secretion of newly synthesized hepatic proteins, and had a delayed onset and termination of action on inhibition of apoB secretion. Vanadates apolipoprotein B Rattus norvegicus
5 In conclusion, our data indicate that vanadate mimics insulin action in hepatocytes with regard to the inhibition of medium accumulation of apoB. Vanadates apolipoprotein B Rattus norvegicus
6 These data are consistent with the hypothesis that inhibition of apoB secretion may be secondary to an increase in phosphotyrosine content at its site of synthesis. Phosphotyrosine apolipoprotein B Rattus norvegicus